QS - you quoted the company as stating: "DoMark has invested in five great innovative products, and we are well positioned to return substantial growth for our investors"
Which 5 products are you referring to? I count only 4 to date including:
1. Musclefoot/Barefoot Science - Discountinued product line 2. SolaPad - product discountinued 3. SolaCase - product discountinued 4. IR Charger (pending release in August)
Regarding shareholder return, the company had gross sales of $1396 (less $483 in cost of sales) for the Musclefoot and SolaPad/Case sales last quarter in exchange for a $6 million license fee - it is disingenious to state that this is "substantial growth for our investors"!
Market Data 
Markets 
AI
